This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schotte, H Articles by Schlüter, B Search for Related Content PubMed PubMed Citation Articles by Schotte, H Articles by Schlüter, B Social Bookmarking                         What's this?

The transforming growth factor-ß1 gene polymorphism (G915C) is not associated with systemic lupus erythematosus

Medizinische Klinik und Poliklinik B, Universitätsklinikum, Münster, Germany, h.schotte{at}uni-muenster.de

P Willeke

Medizinische Klinik und Poliklinik B, Universitätsklinikum, Münster, Germany

S Rust

Institut für Arterioskleroseforschung, Universitätsklinikum, Münster, Germany

G Assmann

Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsklinikum, Münster, Germany, Institut für Arterioskleroseforschung, Universitätsklinikum, Münster, Germany

W Domschke

Medizinische Klinik und Poliklinik B, Universitätsklinikum, Münster, Germany

M Gaubitz

Medizinische Klinik und Poliklinik B, Universitätsklinikum, Münster, Germany

B Schlüter

Institut für Klinische Chemie und Laboratoriumsmedizin, Universitätsklinikum, Münster, Germany

Lymphocyte production of transforming growth factor (TGF)-ß₁ is decreased in systemic lupus erythematosus (SLE). The lack of this immunoregulatory cytokine may contribute to the characteristic T cell disregulation and aberrant B cell stimulation in SLE patients. The less common C allele of the TGFB1 polymorphism (G915C) is associated with a lower TGF-ß₁ production capacity. We performed a population-basedcase - control study to analyse the impact of this polymorphism on disease susceptibility, on clinical SLE manifestations and autoantibody production. A total of 203 German Caucasian SLE patients (fulfilling the 1982 ACR criteria, disease duration 11.5±7.0 years) and 158 ethnically, age- and sex-matched healthy controls were genotyped with a mutagenically separated polymerase chain reaction. There were no significant differences in the genotype distribution and allele frequencies between patients (915 C = 0.08) and healthy controls (915 C = 0.10). Comparing subgroups of patients, we found no association of major disease manifestations or specific autoantibodies with TGFB1 genotypes or alleles. The TGFB1 polymorphism (G915C) neither significantly contributes to the disease susceptibility, nor predisposes to clinical and immunological manifestations typical of SLE. Further studies are needed to corroborate the pathogenic role of TGF-ß₁ in SLE patients and to identify the precise genetic elements controlling its production.

Key Words: systemic lupus erythematosus • transforming growth factor-ß • genetics • polymorphisms • case - control studies

Lupus, Vol. 12, No. 2, 86-92 (2003)
DOI: 10.1191/0961203303lu336oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?